Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.44 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21269213 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL28314445 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL28314627 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL21269292 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL21268958 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL28316200 | 0.98 | SRC (0.58) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL28314388 | 0.95 | SRC (0.56) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL2427033 | 0.89 | SRC (0.48) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL11212242 | 0.89 | LMNA (0.50) | SRCALDH1A1SMN1; SMN2LMNACES2 | |
| SCHEMBL11212236 | 0.87 | SRC (0.46) | SRCALDH1A1SMN1; SMN2LMNACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219194-A1 | Conjugate which inhibits SH2 domains from binding with phosphoproteins for use in prevention and/or treatment of cancer, diabetes, obesity, autoimmune, inflammatory, metabolic and/or cardiovascular diseases; pharmacokinetics, bioavailability | GEORGETOWN UNIVERSITY (US) | 2007-09-20 | — | — | US | claimed |
| EP-1163262-A1 | PHENYLALANINE DERIVATIVES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056760-A1 | PHENYLALANINE DERIVATIVES | THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-09-28 | — | — | WO | claimed |
| CN-114981081-B | Multilayer container, method for producing the same, and method for producing recycled polyester | 三菱瓦斯化学株式会社 | 2025-03-04 | — | — | CN | disclosed |
| CN-119365507-A | Polyurethane foam | 井上株式会社 | 2025-01-24 | — | — | CN | disclosed |
| WO-2023248535-A1 | POLYURETHANE FOAM | 株式会社イノアックコーポレーション | 2023-12-28 | — | — | WO | disclosed |
| WO-2023248536-A1 | POLYURETHANE FOAM | 株式会社イノアックコーポレーション | 2023-12-28 | — | — | WO | disclosed |
| CN-115397919-B | Antistatic agent for thermoplastic resin | 三洋化成工业株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-116261509-A | Single-layer container, method for producing same, and method for producing recycled polyester | 三菱瓦斯化学株式会社 | 2023-06-13 | — | — | CN | disclosed |
| CN-113165251-B | Multilayer container and method for manufacturing the same | 三菱瓦斯化学株式会社 | 2023-06-13 | — | — | CN | disclosed |
| CN-115243891-A | Multilayer container, method for producing same, and method for producing recycled polyester | 三菱瓦斯化学株式会社 | 2022-10-25 | — | — | CN | disclosed |
| EP-0658548-A1 | Benzenesulfonamide derivative and process for preparing thereof | TANABE SEIYAKU CO., LTD. (JP) | 1995-06-21 | — | — | EP | disclosed |
| EP-0355017-B1 | Method for producing a block copolyamide | MITSUBISHI CHEM IND (JP) | 1994-06-15 | — | — | EP | disclosed |
| EP-0510526-A1 | Use of sulfonamides as drug and new sulfonamides | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1992-10-28 | — | — | EP | disclosed |
| US-5011893-A | Condensation polymerization of dimerized fatty acids, diamines and lactams | MITSUBISHI KASEI CORPORATION (JP) | 1991-04-30 | — | — | US | disclosed |
| EP-0355017-A2 | Method for producing a block copolyamide | Mitsubishi Chemical Corporation (JP) | 1990-02-21 | — | — | EP | disclosed |
| US-4892921-A | LIQUID CRYSTAL POLYMERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1990-01-09 | — | — | US | disclosed |
| US-4835246-A | Pendant benzazole rigid-rod aromatic heterocyclic polymer | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1989-05-30 | — | — | US | disclosed |
| US-4785115-A | INTERMEDIATES FOR HETEROCYCLIC POLYMERS OF COMPRESSIVE STRENGTH | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE UNITED STATES (US) | 1988-11-15 | — | — | US | disclosed |
| US-3988326-A | Process for N-acylation of 7 amino cephem compounds | MEIJI SEIKA KAISHA, LTD. (JA) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219194-A1 | Conjugate which inhibits SH2 domains from binding with phosphoproteins for use in prevention and/or treatment of cancer, diabetes, obesity, autoimmune, inflammatory, metabolic and/or cardiovascular diseases; pharmacokinetics, bioavailability | TYRO3, PTMS, ACP1 | SRC 7/4885ALDH1A1 3894/4885SMN1; SMN2 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.